ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 67 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $527,000 | +160.9% | 113,437 | +85.3% | 0.00% | +50.0% |
| Q4 2020 | $202,000 | -2.4% | 61,218 | -2.3% | 0.00% | -33.3% |
| Q3 2020 | $207,000 | -57.6% | 62,645 | -56.7% | 0.00% | -62.5% |
| Q2 2020 | $488,000 | +369.2% | 144,760 | +739.0% | 0.01% | +700.0% |
| Q4 2019 | $104,000 | +15.6% | 17,254 | +44.9% | 0.00% | 0.0% |
| Q3 2019 | $90,000 | -32.3% | 11,909 | -51.3% | 0.00% | 0.0% |
| Q1 2019 | $133,000 | +9.9% | 24,453 | +64.5% | 0.00% | 0.0% |
| Q3 2018 | $121,000 | -9.7% | 14,861 | +8.1% | 0.00% | -50.0% |
| Q2 2018 | $134,000 | -46.0% | 13,742 | -30.7% | 0.00% | -50.0% |
| Q4 2017 | $248,000 | – | 19,843 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Beryl Capital Management LLC | 4,898,927 | $6,246,132 | 0.70% |
| Yakira Capital Management, Inc. | 620,019 | $790,524 | 0.22% |
| Crystalline Management Inc. | 230,817 | $294,292 | 0.21% |
| DELTEC ASSET MANAGEMENT LLC | 475,000 | $605,625 | 0.14% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,283,979 | $2,912,073 | 0.12% |
| PenderFund Capital Management Ltd. | 123,444 | $213 | 0.06% |
| FIFTH LANE CAPITAL, LP | 100,000 | $127,000 | 0.04% |
| CSS LLC/IL | 476,831 | $607,960 | 0.04% |
| Penserra Capital Management LLC | 220,858 | $280 | 0.01% |
| King Wealth Management Group | 16,000 | $20 | 0.00% |